Advanced Cell Technology eliminates $3 million in debt, strengthens balance sheet

Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC) announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.

"We are pleased that we have taken these important steps to create long-term value for shareholders," said William M. Caldwell IV, Chairman and CEO of ACT. "For the past three years, the monthly amortization of certain debentures and conversion to equity of other indebtedness has contributed to a regular supply of stock that has adversely impacted trading. We hope that with the elimination of most of that debt that our stock will begin to reflect the Company's significant recent accomplishments and the potential for our technology platform in the future."